Hostname: page-component-74656f9884-qr5l4 Total loading time: 0 Render date: 2026-11-05T06:06:18.196Z Has data issue: false hasContentIssue false

Network meta-analysis and diffusion

Published online by Cambridge University Press:  15 October 2026

Gerta Rücker*
Affiliation:
Institute of Medical Biometry and Statistics, Medical Center – University of Freiburg , Germany
Annabel Louisa Davies
Affiliation:
Bristol Medical School, University of Bristol , UK
Guido Schwarzer
Affiliation:
Institute of Medical Biometry and Statistics, Medical Center – University of Freiburg , Germany
*
Corresponding author: Gerta Rücker; Email: gertaruecker@aol.com
Rights & Permissions [Opens in a new window]

Abstract

We show that the covariance matrix of the treatment effect estimates in a network meta-analysis can be obtained without matrix inversion using a geometric series of diffusion matrices. This property extends to the hat matrix and provides a connection between parameter estimation in regression analysis and random walks on the network graph. We also provide a number of visualization tools implemented in R.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Research Synthesis Methodology
Figure 0

Figure 1. Example network graphs. Left panel: A fictitious network with five treatments and seven studies. Middle panel: Network graph of the Dong 2013 data. ICS, inhaled corticosteroid; LABA, long-acting β2$\beta 2$ agonist; TIO-HH, tiotropium dry powder delivered via HandiHaler; TIO-SMI, tiotropium solution delivered via Respimat Soft Mist Inhaler. Right panel: Network graph of the Jalota 2011 data. Ante, Antecubital vein; Hand, Hand vein; Lido-prop, Lidocaine–propofol admixture; Lido-pre, Lidocaine pretreatment; Keta-pre, pretreatment with ketamine; NSAIDS-pre, pretreatment with non-steroidal anti-inflammatory drugs; Opioid-pre, Pretreatment with opioids.Figure 1 long description.

Figure 1

Figure 2. Diffusion process for Example 1, starting in node A.Figure 2 long description.

Figure 2

Figure 3. A network with five colored nodes and corresponding drinks. Walkers are spreading through the network in steps, taking a sip of their own drink at every station they visit.

Figure 3

Figure 4. Walkers-and-drinks model for Example 1. The bars represent bottles with juice left after 50 steps and scaling. Each block of bars belongs to a node, each bar in a particular color belongs to the walkers from a particular node. Yellow = A, orange = B, red = C, green = D, and violet = E.Figure 4 long description.

Figure 4

Figure 5. Iterative estimation of the treatment effects for Example 2. The starting points of the lines (to the left of step 0) are the observed treatment effects from 82 comparisons. Each number at the bottom represents the weighted sum of squared distances of the estimates from the final NMA estimates.Figure 5 long description.

Figure 5

Figure 6. Walkers-and-drinks model for Example 2. The bars represent bottles with juice left after 50 steps and scaling. Each block of bars belongs to a node, each bar in a particular color belongs to the walkers from a particular node. Yellow = ICS, orange = LABA, red = LABA-ICS, green = Placebo, violet = TIO-HH, and blue = TIO-SMI.Figure 6 long description.

Figure 6

Figure 7. Simple diffusion for Example 3, starting with uniform distribution. The numbers are the percentage weighted degrees.Figure 7 long description.

Figure 7

Figure 8. Iterative estimation of the treatment effects for Example 3. The starting points of the lines are the observed treatment effects from 108 comparisons. Top left: Simple method, 1,000 steps; Top right: Lazy walk, 10 steps. Bottom left: Absorbing walk, reference is Lidocaine–propofol admixture, 10 steps. Bottom right: Absorbing walk, reference is Hand vein, 10 steps. Each number at the bottom represents the weighted sum of squared distances of the estimates from the final NMA estimates.Figure 8 long description.

Figure 8

Figure E1. Iterative estimation of the treatment effects for Example 3 based on the random-effects model. The starting points of the lines are the observed treatment effects from 108 comparisons. Top left: Simple method, 1,000 steps; Top right: Lazy walk, 10 steps. Bottom left: Absorbing walk, reference is Lidocaine–propofol admixture, 10 steps. Bottom right: Absorbing walk, reference is Hand vein, 10 steps. Each number at the bottom represents the weighted sum of squared distances of the estimates from the final NMA estimates.Figure E1 long description.